Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Execs to Participate in $5M Stock Purchase

NEW YORK (GenomeWeb News) - Acacia Research said yesterday that it has received commitments for the purchase of $5 million in Acacia Research-CombiMatrix common stock and warrants through a direct offering that includes several CombiMatrix executives. 
 
Acacia plans to sell 6.8 million units at $.738 per share to "a select group of investors" including CombiMatrix President and CEO Amit Kumar and company directors Tom Akin and John Abeles.
 
The company said each share will consist of a share of Acacia-CombiMatrix common stock and a five-year warrant to buy 1.5 shares at a price of $.55 per share.
 
Kumar said in a statement that the financing will strengthen CombiMatrix's balance sheet as it prepares to split from parent company Acacia, a plan that it announced in January.
 
The financing also “provides additional capital to fund our expansion in the molecular diagnostics market," Kumar said.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.